• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Delisted patents from the Rx, OTC, and Disc drug lists are displayed in individual tables below.


The following search results are a list of patents that have been DELISTED from the latest Edition (delistings since January 25, 2013 ) of the Orange Book. Search results display delisted patents from drug products on the RX list.

Appl No Prod No Active Ingredient Proprietary Name Delisted Patent
N021795 001 DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE 7022340
N021795 002 DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE 7022340
N021027 001 DOXERCALCIFEROL HECTOROL 7148211
N021027 001 DOXERCALCIFEROL HECTOROL 6903083
N021027 002 DOXERCALCIFEROL HECTOROL 7148211
N204275 001 FLUTICASONE FUROATE; VILANTEROL TRIFENATATE BREO ELLIPTA 7361787
N203568 001 MIPOMERSEN SODIUM KYNAMRO 5914396
N203585 001 OMACETAXINE MEPESUCCINATE SYNRIBO 7842687
N021654 001 OMEGA-3-ACID ETHYL ESTERS LOVAZA 7732488
N020741 002 REPAGLINIDE PRANDIN 6677358
N020741 003 REPAGLINIDE PRANDIN 6677358
N203975 001 UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE ANORO ELLIPTA 7361787



There have been no patent delistings from the Orange Book in the OTC list since the last Annual Edition.





There have been no patent delistings from the Orange Book in the DISC list since the last Annual Edition.


Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through February 2015
Patent and Generic Drug Product Data Last Updated March 31, 2015

-
-